Coronary artery diameter and left ventricular function in patients on maintenance hemodialysis treatment: comparison

K Hatada1, T Sugiura, S Nakamura

  • 1Second Department of Internal Medicine, Kansai Medical University, Osaka, Japan. hatada@takii.kmu.ac.jp

Nephron
|November 10, 1998
PubMed

Insights

Diabetes mellitus in patients undergoing hemodialysis is linked to narrower coronary arteries and increased left ventricular end-diastolic pressure, despite no significant blockages. This impacts cardiac function in end-stage renal disease patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Diabetology

Background:

  • End-stage renal disease (ESRD) patients on maintenance hemodialysis often have cardiovascular complications.
  • Diabetes mellitus is a significant risk factor for cardiovascular disease in ESRD.
  • The impact of diabetes on coronary artery dimensions and left ventricular function in ESRD patients requires further investigation.

Purpose of the Study:

  • To investigate the role of diabetes mellitus in determining left ventricular function.
  • To evaluate coronary artery diameter in patients with ESRD undergoing maintenance hemodialysis.
  • To assess the relationship between diabetes, coronary artery dimensions, and left ventricular pressures.

Main Methods:

  • A comparative study of 12 diabetic and 12 non-diabetic ESRD patients on maintenance hemodialysis.
  • Echocardiography to measure left ventricular dimensions and wall thickness.
  • Coronary angiography with computed densitometry to measure coronary artery diameter and assess calcification.

Main Results:

  • Diabetic patients exhibited significantly smaller coronary artery diameters and a higher frequency of coronary artery calcification compared to non-diabetic patients.
  • No significant differences were observed in left ventricular wall thickness, diameter, mean right atrial pressure, or cardiac index between the groups.
  • Left ventricular end-diastolic pressure was significantly higher in diabetic patients (22 ± 9 mm Hg) than in non-diabetic patients (14 ± 5 mm Hg).

Conclusions:

  • Diffuse luminal narrowing of epicardial coronary arteries in diabetic ESRD patients on hemodialysis is associated with increased left ventricular end-diastolic pressure.
  • Diabetes mellitus contributes to coronary artery abnormalities in ESRD patients, impacting cardiac hemodynamics.
  • These findings highlight the importance of managing diabetes to mitigate cardiovascular risk in ESRD patients on hemodialysis.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...